Back
WuXi Biologics (Cayman) Vs. CASI Pharmaceuticals Industry Stock Comparison
Buy
78
WXIBF
WuXi Biologics (Cayman)
Last Price:
2.50
Seasonality Move:
2.73%
Sell
21
CASI
CASI Pharmaceuticals
Last Price:
3.17
Seasonality Move:
-0.11%
Buy
78
WuXi Biologics (Cayman) (WXIBF)
is a Buy
Is WuXi Biologics (Cayman) a Buy, Sell or Hold?
- The current WuXi Biologics (Cayman) [WXIBF] share price is $2.50. The Score for WXIBF is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- WXIBF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
CASI Pharmaceuticals (CASI)
is a Sell
Is CASI Pharmaceuticals a Buy, Sell or Hold?
- The current CASI Pharmaceuticals [CASI] share price is $3.11. The Score for CASI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- CASI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WXIBF Stock Price Chart
What is WuXi Biologics (Cayman)'s stock price today?
-
The WuXi Biologics (Cayman) share price today is $2.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WXIBF is experiencing slight buying pressure.
CASI Stock Price Chart
What is CASI Pharmaceuticals's stock price today?
-
The CASI Pharmaceuticals share price today is $3.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing selling pressure, which indicates risk of future bearish movement.
WXIBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 80.77 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.78 - 2.32) | Buy |
| Bollinger Bands (100): | (1.36 - 2.32) | Buy |
CASI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 33.37 | Sell |
| Chaikin Money Flow: | -44072 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.42 - 5.4) | Sell |
| Bollinger Bands (100): | (4.76 - 6.88) | Sell |
WXIBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.26 | Buy |
| 20-day SMA: | 2.02 | Buy |
| 50-day SMA: | 2.25 | Buy |
| 200-day SMA: | 1.79 | Buy |
| 8-day EMA: | 2.32 | Buy |
| 20-day EMA: | 2.16 | Buy |
| 50-day EMA: | 2.09 | Buy |
| 200-day EMA: | 2.26 | Buy |
CASI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.31 | Sell |
| 20-day SMA: | 4.1 | Sell |
| 50-day SMA: | 5.11 | Sell |
| 200-day SMA: | 4.81 | Sell |
| 8-day EMA: | 3.38 | Sell |
| 20-day EMA: | 3.98 | Sell |
| 50-day EMA: | 4.81 | Sell |
| 200-day EMA: | 5.05 | Sell |
WuXi Biologics (Cayman) Earnings Growth & WXIBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
WuXi Biologics (Cayman) Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CASI Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||